Home » Topics » Regulatory

Regulatory
RSS

Lilly reports new treatment for attention deficit/hyperactivity disorder

Sep. 13, 1996

Rhodanines for multiple sclerosis

Sep. 13, 1996

New formulation of selegiline

Sep. 13, 1996

Known antipsychotic claimed for drug dependence

Sep. 13, 1996

Rapamycin in anemia

Sep. 13, 1996

Novel treatment for bone loss

Sep. 13, 1996

U.S. approval for glaucoma medication

Sep. 13, 1996

Seratrodast claimed for the treatment of atopic dermatitis

Sep. 13, 1996

Liarozole claimed for inhibiting calcitriol metabolism

Sep. 13, 1996

Controlled-release oral analgesic formulation claimed by Euroceltique

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...